Which of the following statements is NOT true regarding disorders of homocysteine metabolism? A) Increased plasma homocysteine concentration B) Increased risk of vascular disease (arterial and venous thrombosis) C) Osteopetrosis D) Improvement with pyridoxine (vitamin B6) and folic acid (folate) administration E) Tall stature with Marfanoid features

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

The Answer is C) Osteopetrosis

Osteopetrosis is NOT a feature of disorders of homocysteine metabolism. This bone condition characterized by increased bone density is unrelated to homocysteine disorders, which instead cause osteoporosis (decreased bone density) along with skeletal abnormalities.

Why the Other Options ARE True:

A) Increased Blood Homocysteine Concentration

This is the defining feature of these disorders. Homocystinuria and related conditions are characterized by elevated plasma homocysteine levels, ranging from mild elevations (15-30 μmol/L) to severe hyperhomocysteinemia (>100 μmol/L) 1, 2.

B) Increased Risk of Vascular Disease

Hyperhomocysteinemia is strongly associated with both arterial and venous thrombosis. The evidence demonstrates that elevated homocysteine causes:

  • Endothelial cell damage and dysfunction
  • Enhanced platelet reactivity and thrombin generation
  • Impaired fibrinolytic potential
  • Increased tissue factor expression
  • Oxidative stress leading to vascular injury

This creates a prothrombotic state affecting both arterial (coronary, cerebral, peripheral) and venous systems 1, 3, 4.

D) Improvement with Pyridoxine and Folic Acid

Treatment with B vitamins is the cornerstone of management for homocysteine disorders. For cystathionine β-synthase (CBS) deficiency, the most common form:

  • Pyridoxine-responsive patients: 50-250 mg/day pyridoxine combined with folic acid (0.4-5 mg/day) and/or vitamin B12 (0.02-1 mg/day)
  • This combination consistently lowers plasma homocysteine by 25-30% with folic acid alone, with additional reduction from B12 supplementation 1

E) Tall Stature with Marfanoid Features

Classical homocystinuria (CBS deficiency) presents with a characteristic phenotype including:

  • Tall stature
  • Marfanoid habitus (long limbs, arachnodactyly)
  • Ectopia lentis (lens dislocation)
  • Skeletal abnormalities including osteoporosis (not osteopetrosis)
  • Intellectual disability in untreated cases

The Critical Distinction

The skeletal manifestation in homocysteine disorders is osteoporosis (bone loss), not osteopetrosis (excessive bone density). This occurs due to the effects of elevated homocysteine on bone metabolism and collagen cross-linking 5, 6.

Related Questions

What should be done when the erythrocyte sedimentation rate is normal but plasma homocysteine is elevated?
Is colchicine contraindicated in individuals homozygous for MTRR gene variants that affect homocysteine metabolism?
How should I assess and manage an adult with unexplained thrombotic events, premature coronary artery disease, stroke, or a family history of hyperhomocysteinemia regarding elevated homocysteine levels?
What is the normal plasma homocysteine concentration, what are the clinical implications of elevated homocysteine levels, and how should homocysteinemia be treated?
In a patient in their late 80s with elevated homocysteine, normal vitamin B12 (cobalamin) and folate (folic acid), and near‑normal renal function, what is the appropriate management?
What medication can suppress premature ventricular contractions (PVCs) without decreasing heart rate in a patient without structural heart disease, coronary artery disease, or heart failure?
What is the likely cause and appropriate management for a unilateral eyelid twitch in a healthy 16‑year‑old male?
Can you interpret the imaging for a patient with a 4‑5 day history of worsening cough, intermittent hemoptysis, dyspnea, upper‑back discomfort when coughing, sleep disruption requiring multiple pillows, and recent loose stools (≈4 bowel movements daily) without recent upper respiratory infection or nasal bleeding?
What is the significance of a total iron-binding capacity of 231 µg/dL and a ferritin level of 200 ng/mL?
What are the problems associated with continuing pantoprazole 40 mg twice daily and famotidine twice daily for gastroesophageal reflux disease?
How should constipation be managed safely in pregnant patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.